Public offering nets $87mm for GlycoMimetics

19:41 EDT 25 May 2017 | Elsevier Business Intelligence

GlycoMimetics Inc. (therapies for cancer and vaso-occlusive crisis in sickle cell disease) publicly sold 8mm common shares (i...

Original Article: Public offering nets $87mm for GlycoMimetics


More From BioPortfolio on "Public offering nets $87mm for GlycoMimetics"

Quick Search


Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...